For the thousands of Indian families living with transfusion-dependent thalassemia, 2026 brings a new horizon of hope: the arrival of Affordable Genomic Medicine. While gene therapies like CRISPR-based treatments have been available globally, their multi-million dollar price tags remained out of reach for the average Indian patient. This year, however, domestic biotech firms and research...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai
English
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china